Annual CFO
-$64.09 M
+$78.38 M+55.01%
September 30, 2024
Summary
- As of February 7, 2025, TWST annual cash flow from operations is -$64.09 million, with the most recent change of +$78.38 million (+55.01%) on September 30, 2024.
- During the last 3 years, TWST annual CFO has risen by +$48.15 million (+42.90%).
- TWST annual CFO is now -66.08% below its all-time high of -$38.59 million, reached on September 30, 2016.
Performance
TWST Cash From Operations Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
High & Low
Earnings dates
Quarterly CFO
-$21.43 M
-$6.11 M-39.87%
December 31, 2024
Summary
- As of February 7, 2025, TWST quarterly cash flow from operations is -$21.43 million, with the most recent change of -$6.11 million (-39.87%) on December 31, 2024.
- Over the past year, TWST quarterly CFO has dropped by -$15.05 million (-235.97%).
- TWST quarterly CFO is now -1591.24% below its all-time high of -$1.27 million, reached on September 30, 2022.
Performance
TWST Quarterly CFO Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
High & Low
Earnings dates
TTM CFO
-$62.55 M
+$1.54 M+2.41%
December 31, 2024
Summary
- As of February 7, 2025, TWST TTM cash flow from operations is -$62.55 million, with the most recent change of +$1.54 million (+2.41%) on December 31, 2024.
- Over the past year, TWST TTM CFO has increased by +$6.93 million (+9.97%).
- TWST TTM CFO is now -290.54% below its all-time high of -$16.02 million, reached on December 31, 2017.
Performance
TWST TTM CFO Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
High & Low
Earnings dates
Cash From Operations Formula
CFO = Net Income + Non Cash Expenses + Changes In Working Capital
TWST Cash From Operations Trends
PeriodPeriod | AnnualAnnual | QuarterlyQuarterly | TTMTTM |
---|---|---|---|
1 y1 year | +55.0% | -236.0% | +10.0% |
3 y3 years | +42.9% | +54.1% | +53.3% |
5 y5 years | +27.1% | +38.6% | +38.2% |
TWST Cash From Operations Highs & Lows
PeriodPeriod | Annual vs highAnnual vs high | Annual vs lowAnnual vs low | Quarter. vs highQuarter. vs high | Quarter. vs lowQuarter. vs low | TTM vs highTTM vs high | TTM vs lowTTM vs low | |
---|---|---|---|---|---|---|---|
3 y | 3-year | at high | +55.0% | -1591.2% | +60.4% | at high | +60.4% |
5 y | 5-year | at high | +55.0% | -1591.2% | +63.5% | at high | +60.4% |
alltime | all time | -66.1% | +55.0% | -1591.2% | +63.5% | -290.5% | +60.4% |
Twist Bioscience Cash From Operations History
Date | Annual | Quarterly | TTM |
---|---|---|---|
Dec 2024 | - | -$21.43 M(+39.9%) | -$62.55 M(-2.4%) |
Sep 2024 | -$64.09 M(-55.0%) | -$15.32 M(+140.2%) | -$64.09 M(-7.7%) |
Jun 2024 | - | -$6.38 M(-67.2%) | -$69.48 M(-19.7%) |
Mar 2024 | - | -$19.42 M(-15.5%) | -$86.51 M(-22.3%) |
Dec 2023 | - | -$22.97 M(+11.0%) | -$111.38 M(-21.8%) |
Sep 2023 | -$142.47 M(+14.5%) | -$20.70 M(-11.6%) | -$142.47 M(+15.8%) |
Jun 2023 | - | -$23.41 M(-47.1%) | -$123.04 M(-8.0%) |
Mar 2023 | - | -$44.29 M(-18.1%) | -$133.75 M(+1.5%) |
Dec 2022 | - | -$54.07 M(+4167.6%) | -$131.80 M(+6.0%) |
Sep 2022 | -$124.39 M(+10.8%) | -$1.27 M(-96.3%) | -$124.39 M(-21.2%) |
Jun 2022 | - | -$34.13 M(-19.4%) | -$157.92 M(+4.1%) |
Mar 2022 | - | -$42.34 M(-9.2%) | -$151.76 M(+13.3%) |
Dec 2021 | - | -$46.65 M(+34.0%) | -$133.97 M(+19.4%) |
Sep 2021 | -$112.24 M | -$34.80 M(+24.5%) | -$112.24 M(+9.4%) |
Jun 2021 | - | -$27.96 M(+13.9%) | -$102.64 M(+4.6%) |
Date | Annual | Quarterly | TTM |
---|---|---|---|
Mar 2021 | - | -$24.55 M(-1.5%) | -$98.15 M(-25.8%) |
Dec 2020 | - | -$24.93 M(-1.1%) | -$132.27 M(-7.0%) |
Sep 2020 | -$142.25 M(+61.8%) | -$25.20 M(+7.4%) | -$142.25 M(+1.3%) |
Jun 2020 | - | -$23.47 M(-60.0%) | -$140.41 M(+1.0%) |
Mar 2020 | - | -$58.67 M(+68.0%) | -$139.03 M(+37.4%) |
Dec 2019 | - | -$34.91 M(+49.5%) | -$101.17 M(+15.0%) |
Sep 2019 | -$87.94 M(+32.9%) | -$23.36 M(+5.8%) | -$87.94 M(+8.2%) |
Jun 2019 | - | -$22.08 M(+6.1%) | -$81.28 M(+6.8%) |
Mar 2019 | - | -$20.81 M(-4.0%) | -$76.14 M(+6.0%) |
Dec 2018 | - | -$21.68 M(+29.9%) | -$71.83 M(+8.6%) |
Sep 2018 | -$66.16 M(+29.0%) | -$16.70 M(-1.5%) | -$66.16 M(+33.8%) |
Jun 2018 | - | -$16.94 M(+2.6%) | -$49.47 M(+52.1%) |
Mar 2018 | - | -$16.51 M(+3.1%) | -$32.53 M(+103.1%) |
Dec 2017 | - | -$16.02 M | -$16.02 M |
Sep 2017 | -$51.30 M(+32.9%) | - | - |
Sep 2016 | -$38.59 M | - | - |
FAQ
- What is Twist Bioscience annual cash flow from operations?
- What is the all time high annual CFO for Twist Bioscience?
- What is Twist Bioscience annual CFO year-on-year change?
- What is Twist Bioscience quarterly cash flow from operations?
- What is the all time high quarterly CFO for Twist Bioscience?
- What is Twist Bioscience quarterly CFO year-on-year change?
- What is Twist Bioscience TTM cash flow from operations?
- What is the all time high TTM CFO for Twist Bioscience?
- What is Twist Bioscience TTM CFO year-on-year change?
What is Twist Bioscience annual cash flow from operations?
The current annual CFO of TWST is -$64.09 M
What is the all time high annual CFO for Twist Bioscience?
Twist Bioscience all-time high annual cash flow from operations is -$38.59 M
What is Twist Bioscience annual CFO year-on-year change?
Over the past year, TWST annual cash flow from operations has changed by +$78.38 M (+55.01%)
What is Twist Bioscience quarterly cash flow from operations?
The current quarterly CFO of TWST is -$21.43 M
What is the all time high quarterly CFO for Twist Bioscience?
Twist Bioscience all-time high quarterly cash flow from operations is -$1.27 M
What is Twist Bioscience quarterly CFO year-on-year change?
Over the past year, TWST quarterly cash flow from operations has changed by -$15.05 M (-235.97%)
What is Twist Bioscience TTM cash flow from operations?
The current TTM CFO of TWST is -$62.55 M
What is the all time high TTM CFO for Twist Bioscience?
Twist Bioscience all-time high TTM cash flow from operations is -$16.02 M
What is Twist Bioscience TTM CFO year-on-year change?
Over the past year, TWST TTM cash flow from operations has changed by +$6.93 M (+9.97%)